The Venture Codex Logo

The Venture Codex

University of California, San Francisco

500 Parnassus Ave, San Francisco, CA, 94143, United States

Overview

Advanced cytometry and biomedical technology research and development.

Deals ยท 12mo

0

Stage focus

Series A
Series B

Geographic focus

United States

Sector focus

Association
Biotechnology
Education
Medical
...

Investment portfolio

2rounds
NAMEDATESIZE
ArsenalBio
Sep 2022Participated
$220 MSeries B
ArsenalBio
Oct 2019Participated
$85 MSeries A
ArsenalBio
Sep 2022Participated
$220 MSeries B
ArsenalBio
Oct 2019Participated
$85 MSeries A
2
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

University of California, San Francisco: 2 funding rounds are recorded in the selected participation categories.All available history.
University of California, San Francisco: 2 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A01
Series B01

Monthly Deal Activity

University of California, San Francisco: 2 deals are recorded across 85 months.All available history.
University of California, San Francisco: 2 deals are recorded across 85 months. All available history
MonthDeals
Oct '191
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '221
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

University of California, San Francisco: Enterprise Software is the largest displayed sector by deal count (2 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

University of California, San Francisco: Enterprise Software is the largest displayed sector by deal count (2 deals). All available history
SectorDeals
Enterprise Software2
Health & Life Sciences2

Deal Size Distribution

University of California, San Francisco: 2 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

University of California, San Francisco: 2 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M0
$25M-$50M0
$50M-$100M1
$100M-$250M1
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

University of California, San Francisco: United States has the largest recorded deal count among the displayed regions (2 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

University of California, San Francisco: United States has the largest recorded deal count among the displayed regions (2 deals). All available history
RegionDeals
United States2
University of California, San Francisco: 13 co-investors are shown, with Euclidean Capital sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

University of California, San Francisco: 13 co-investors are shown, with Euclidean Capital sharing 2 recorded deals. All available history
Co-investorShared deals
Euclidean Capital2
Kleiner Perkins2
Parker Institute for Cancer Immunotherapy2
Westlake Village BioPartners2
Bristol Myers Squibb1
Byers Capital1
Emerson Collective1
Green Sands Equity1
Hitachi Ventures1
Osage Venture Partners1
Sixth Street Growth1
SoftBank1
Waycross Ventures1

Investment Strategy

University of California, San Francisco: Led accounts for 0% and participating for 100% of round participation.All available history.
University of California, San Francisco: Led accounts for 0% and participating for 100% of round participation. All available history
CategoryDeals (count)Share (%)
Led00%
Participating2100%
University of California, San Francisco: Single-lead accounts for 0% and co-led for 0% of lead dynamics.All available history.
University of California, San Francisco: Single-lead accounts for 0% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led00%

Lead dynamics requires at least one led deal in this range

Team

Alejandro Sweet-Cordero

Associate Professor

Ganz Peter

Chief of Cardiology, San Francisco General Hospital & Professor of Medicine

Haig Alexander Eskandarian

Research Scientist

James Wells

Professor

Marc Kohli, MD FSIIM

Associate Chair of Clinical Informatics

Matthew Garibaldi

Associate Clinical Professor & Director of Orthotics & Prosthetics

Patrick Phelan

Chief Information Security Officer

Sanchita Bhattacharya

Scientific Program Director